164 related articles for article (PubMed ID: 16550036)
1. Drug-induced liver disease.
Lewis JH; Ahmed M; Shobassy A; Palese C
Curr Opin Gastroenterol; 2006 May; 22(3):223-33. PubMed ID: 16550036
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced liver injury in patients with underlying liver disease.
Devarbhavi HC; Philips CA
Clin Liver Dis (Hoboken); 2024; 23(1):e0189. PubMed ID: 38860131
[No Abstract] [Full Text] [Related]
3. Dabigatran versus warfarin in patients with atrial fibrillation.
Connolly SJ; Ezekowitz MD; Yusuf S; Eikelboom J; Oldgren J; Parekh A; Pogue J; Reilly PA; Themeles E; Varrone J; Wang S; Alings M; Xavier D; Zhu J; Diaz R; Lewis BS; Darius H; Diener HC; Joyner CD; Wallentin L;
N Engl J Med; 2009 Sep; 361(12):1139-51. PubMed ID: 19717844
[TBL] [Abstract][Full Text] [Related]
4. Update on emerging urate-lowering therapies.
Chohan S; Becker MA
Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; MacFadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
N Engl J Med; 2008 Nov; 359(21):2195-207. PubMed ID: 18997196
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and musculoskeletal health.
Wolff AE; Jones AN; Hansen KE
Nat Clin Pract Rheumatol; 2008 Nov; 4(11):580-8. PubMed ID: 18852718
[TBL] [Abstract][Full Text] [Related]
7. Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy.
Loriot Y; Perlemuter G; Malka D; Penault-Llorca F; Boige V; Deutsch E; Massard C; Armand JP; Soria JC
Nat Clin Pract Oncol; 2008 May; 5(5):268-78. PubMed ID: 18349858
[TBL] [Abstract][Full Text] [Related]
8. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study.
Atasoy N; Erdogan A; Yalug I; Ozturk U; Konuk N; Atik L; Ustundag Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1255-60. PubMed ID: 17600607
[TBL] [Abstract][Full Text] [Related]
9. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
Ullmann AJ; Lipton JH; Vesole DH; Chandrasekar P; Langston A; Tarantolo SR; Greinix H; Morais de Azevedo W; Reddy V; Boparai N; Pedicone L; Patino H; Durrant S
N Engl J Med; 2007 Jan; 356(4):335-47. PubMed ID: 17251530
[TBL] [Abstract][Full Text] [Related]
10. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
Motzer RJ; Hutson TE; Tomczak P; Michaelson MD; Bukowski RM; Rixe O; Oudard S; Negrier S; Szczylik C; Kim ST; Chen I; Bycott PW; Baum CM; Figlin RA
N Engl J Med; 2007 Jan; 356(2):115-24. PubMed ID: 17215529
[TBL] [Abstract][Full Text] [Related]
11. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
[TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
Belfort R; Harrison SA; Brown K; Darland C; Finch J; Hardies J; Balas B; Gastaldelli A; Tio F; Pulcini J; Berria R; Ma JZ; Dwivedi S; Havranek R; Fincke C; DeFronzo R; Bannayan GA; Schenker S; Cusi K
N Engl J Med; 2006 Nov; 355(22):2297-307. PubMed ID: 17135584
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic.
De Valle MB; Av Klinteberg V; Alem N; Olsson R; Björnsson E
Aliment Pharmacol Ther; 2006 Oct; 24(8):1187-95. PubMed ID: 17014577
[TBL] [Abstract][Full Text] [Related]
14. Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports.
Sanchez-Matienzo D; Arana A; Castellsague J; Perez-Gutthann S
Clin Ther; 2006 Aug; 28(8):1123-1132. PubMed ID: 16982289
[TBL] [Abstract][Full Text] [Related]
15. Fatty liver and transaminase changes with adjuvant tamoxifen therapy.
Liu CL; Huang JK; Cheng SP; Chang YC; Lee JJ; Liu TP
Anticancer Drugs; 2006 Jul; 17(6):709-13. PubMed ID: 16917217
[TBL] [Abstract][Full Text] [Related]
16. HIV-protease inhibitors.
Flexner C
N Engl J Med; 1998 Apr; 338(18):1281-92. PubMed ID: 9562584
[No Abstract] [Full Text] [Related]
17. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.
Negrier S; Escudier B; Lasset C; Douillard JY; Savary J; Chevreau C; Ravaud A; Mercatello A; Peny J; Mousseau M; Philip T; Tursz T
N Engl J Med; 1998 Apr; 338(18):1272-8. PubMed ID: 9562581
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effect of two hormonal preparations in postmenopausal women.
Bissonnette F; Lussier-Cacan S; Fugère P; Bérubé S
Maturitas; 1997 Jul; 27(3):275-84. PubMed ID: 9288700
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of class I antiarrhythmic drugs.
Caron J; Libersa C
Drug Saf; 1997 Jul; 17(1):8-36. PubMed ID: 9258628
[TBL] [Abstract][Full Text] [Related]
20. Hepatotoxicity of clozapine.
Hummer M; Kurz M; Kurzthaler I; Oberbauer H; Miller C; Fleischhacker WW
J Clin Psychopharmacol; 1997 Aug; 17(4):314-7. PubMed ID: 9241012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
